Home
Scholarly Works
Secukinumab demonstrates sustained efficacy in...
Journal article

Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR study

Authors

Thaçi D; Puig L; Reich K; Tsai T-F; Tyring S; Kingo K; Ziv M; Pinter A; Vender R; Lacombe A

Journal

Journal of the American Academy of Dermatology, Vol. 81, No. 6, pp. 1405–1409

Publisher

Elsevier

Publication Date

December 1, 2019

DOI

10.1016/j.jaad.2019.04.045

ISSN

0190-9622

Contact the Experts team